PBM rebate schemes to suppress biosimilar Humira cost patients $6B, IQVIA analysis findsThe Biosimilars Council released a new analysis by IQVIA that reveals a PBM strategy to protect $2 billion in profits by “strangling” the biosimilar market and preventing savings for patients. FDA gives tentative OK for Lupin’s generic GalafoldMigalastat Capsules are indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. Upsher-Smith launches generic Tapazole Methimazole had a market value of roughly $36.8 million for the 12 months ending December 2023, per IQVIA. Alembic gets tentative nod from FDA for generic Kisqali Ribociclib 200 mg is the generic of Novartis’ Kisqali. Amneal to ring Nasdaq closing bell on April 2, 2024 Amneal is celebrating its recent listing on the Nasdaq Stock Exchange. ANI rolls out generic Levaquin Levofloxacin oral solution is used to treat bacterial infections. Amneal issues nationwide voluntary recall of Vancomycin Hydrochloride for Oral Solution 250 mg/5 mL Some bottles may have been overfilled which can result in an over potent dosing regimen, Amneal said. Lupin receives FDA OK for generic Aptiom Eslicarbazepine Acetate Tablets are indicated for the treatment of partial-onset seizures in patients aged 4 years old and older. Alembic releases generic Zomig Zolmitriptan is a serotonin receptor agonist indicated for the acute treatment of migraine with or without aura in adults. FDA gives Amneal permission for generic Ciprodex Ciprofloxacin and dexamethasone otic suspension is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in Acute Otitis Externa. First Previous 36 37 38 39 40 Next Last
